• News
  • Contact Us

Nancy Pleshko, Ph.D.

Managing Scientist

Biomechanics

(215) 594-8852 tel
(215) 594-8899 fax

Philadelphia

Download vCard
Full CV 

Professional Profile


Dr. Pleshko specializes in assessment of tissues at the molecular, cellular, and structural level through application of state-of-the-art vibrational spectroscopy, including mid- and near-infrared spectroscopy and spectroscopic imaging, in concert with complementary techniques. She has developed substantial expertise over the past 20 years in basic and translational research in connective tissue pathophysiology and orthopedics, including osteoporosis and other bone pathologies, osteoarthritis and cartilage repair, vascular tissue remodeling, as well as in spectroscopic assessment of food quality. Applications include establishing correlations between molecular tissue properties and mechanical and other functional properties, and assessment of therapeutic interventions. This includes evaluation of the effects of biological interventions, such as anti-resorptive agents for bone, as well as characterization of biomaterials for development of engineered tissues. She has further experience in assessment of growth and modification of engineered tissue. Dr. Pleshko also has expertise in the application of imaging modalities, such as micro-CT and MRI, in her tissue and biomaterial evaluations. Dr. Pleshko has extensive experience in the design of experimental and translational research protocols, and in formulating the overall approach to address specific questions related to tissue and materials characterization.

Dr. Pleshko’s research interests have included the characterization of the progression of osteoarthritic changes in bone and cartilage in a number of preclinical osteoarthritis models at the molecular level, and she has developed methodologies for minimally invasive assessment of related molecular alterations in human patients. She is currently developing similar capabilities of clinical outcome predictors in cartilage repair based on molecular features of the tissue. Further, Dr. Pleshko has defined molecular features of mineralization abnormalities in vitro and extended this to preclinical models of bone disease.

Prior to joining Exponent, Dr. Pleshko was the founder and Director of the Musculoskeletal Imaging and Spectroscopy Laboratory at the Hospital for Special Surgery, an affiliate of Weill Cornell Medical School in New York City. Her internationally recognized NIH-funded program focused primarily on cartilage and bone pathology and therapeutics. She also held appointments at Weill Cornell Medical School, and in the Department of Biomedical Engineering at City College in Manhattan.

  • Ph.D., Chemistry, Rutgers University, 1991
  • M.S., Medicinal Chemistry, Rutgers University, 1988
  • B.S., Chemistry, McGill University (with great distinction), 1985
  • Whitehead Fellow in Musculoskeletal Research, Hospital for Special Surgery, NY, 2002
  • Young Investigator Award, 6th International Conference on the Chemistry and Biology of Mineralized Tissues, 1998
  • Eastern Orthopaedic Association Founder's Award, 1996
  • Young Investigator Award, 5th International Conference on the Chemistry and Biology of Mineralized Tissue, 1995
  • NIH Training Grant Recipient, 1992–1994
  • Doctoral Excellence Fellow, Dept. of Chemistry, Rutgers University, NJ, 1986–1990

    • Visiting Research Professor, School of Biomedical Engineering, Drexel University, PA, 2008–current
    • Adjunct Associate Scientist, Hospital for Special Surgery, NY, 2007–current

    Patent 09/853,298: Determination of the Ultrastructure of Connective Tissue by an Infrared Fiber Optic Spectroscopic Probe, 2004; UK Patent 0226099, 2004.

    Patent Application 60/289,984: Discrimination of Host from Non-Host Material With an Infrared Fiber Optic Spectroscopic Probe, 2006; U.K. Patent 03181427, 2005.